{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:24:33Z","timestamp":1793942673237,"version":"4.8.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"28","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HL137913"],"award-info":[{"award-number":["R01HL137913"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HL150538"],"award-info":[{"award-number":["R01HL150538"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HL165453"],"award-info":[{"award-number":["R01HL165453"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HL093717"],"award-info":[{"award-number":["R01HL093717"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL134892"],"award-info":[{"award-number":["1R01HL134892"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL163099\u201301"],"award-info":[{"award-number":["1R01HL163099\u201301"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100029115","name":"Charitable Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100029115","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Simard Fund"},{"name":"Dr. Wael Almahmeed Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reduce cardiovascular events. However, their impact on atherosclerosis and inflammation, regardless of diabetes or obesity, is unknown. Here, GLP-1 RA effects were investigated on (i) atherosclerosis burden and inflammation in vivo in rabbits and (ii) inflammatory biomarkers and major adverse cardiovascular events (MACE) in clinical subjects, adjusted for glycaemic and obesity status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Rabbits with atherosclerosis received liraglutide (0.1 mg\/kg\/day) or saline for 4 weeks. Serial intravascular ultrasound (IVUS) and near-infrared fluorescence-optical coherence tomography (NIRF-OCT) assessed plaque burden and cathepsin activity. Histological, plasma, and in vitro analyses assessed GLP-1 RA effects on atheroinflammation. A clinical study of 47,324 participants from the Mass General Brigham Biobank evaluated the association between GLP-1 RA prescription and inflammatory biomarkers [lymphocyte-based ratios and C-reactive protein (CRP)], and MACE. Analyses included multivariable regression, propensity score matching (PSM), and mediation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 28 normoglycaemic, non-obese rabbits, liraglutide significantly inhibited atherosclerosis progression compared with controls [IVUS \u0394 percent atheroma volume: \u22127.8%, 95% confidence interval (CI) \u221211.3 to \u22124.2; P &amp;lt; .001], and reduced NIRF-OCT plaque cathepsin activity (\u22129.8 nM, 95% CI \u221218.5 to \u22121.1; P = .028). Liraglutide further reduced plaque cathepsin S, macrophage content, and plasma CRP levels. In vitro, multiple GLP-1 RAs suppressed cathepsin activity and inflammatory mediators in macrophages. In biobank patients, GLP-1 RA prescription associated with significantly lower levels of inflammatory biomarkers and MACE in regression and PSM analyses, with benefits persisting in subgroups stratified by body mass index or glycated haemoglobin. Mediation analysis showed inflammatory biomarkers partly contributed to this effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This integrative preclinical\u2013clinical study demonstrates that GLP-1 RAs reduce atherosclerosis progression, inflammatory biomarkers and MACE, irrespective of hyperglycaemia or obesity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehag060","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:41:26Z","timestamp":1772196086000},"page":"3800-3817","source":"Crossref","is-referenced-by-count":15,"title":["Glucagon-like peptide-1 receptor agonists reduce experimental atherosclerosis progression, inflammatory biomarkers and cardiovascular events, irrespective of hyperglycaemia and obesity"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5314-4863","authenticated-orcid":false,"given":"Mohamad B","family":"Kassab","sequence":"first","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0003-5089","authenticated-orcid":false,"given":"Haitham","family":"Khraishah","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]},{"name":"Harrington Heart and Vascular Institute, Case Western Reserve University , Cleveland, OH 44106 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0777-6218","authenticated-orcid":false,"given":"Andrew","family":"Thrapp","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-8881","authenticated-orcid":false,"given":"Shady M","family":"Abohashem","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-1911","authenticated-orcid":false,"given":"Aatira","family":"Vijay","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6908-8758","authenticated-orcid":false,"given":"Thiago","family":"Rentz","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Brigham and Women\u2019s Hospital , Harvard Medical School, Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9848-4855","authenticated-orcid":false,"given":"Du-Ri","family":"Song","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8360-463X","authenticated-orcid":false,"given":"Graham","family":"Spicer","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4327-5568","authenticated-orcid":false,"given":"Guillaume","family":"Goudot","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3949-8558","authenticated-orcid":false,"given":"Mohammed M","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]},{"name":"Division of Vascular Surgery, Department of Surgery, Addenbrooke\u2019s Hospital, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2369-0967","authenticated-orcid":false,"given":"Mazen S","family":"Albaghdadi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-6959","authenticated-orcid":false,"given":"Yoichiro","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0558-4987","authenticated-orcid":false,"given":"Paishiun N","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2470-898X","authenticated-orcid":false,"given":"Adam","family":"Mauskapf","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0487-7531","authenticated-orcid":false,"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , New York 10029, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-502X","authenticated-orcid":false,"given":"Peter","family":"Libby","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Brigham and Women\u2019s Hospital , Harvard Medical School, Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-5483","authenticated-orcid":false,"given":"Ahmed","family":"Tawakol","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8277-4453","authenticated-orcid":false,"given":"Guillermo J","family":"Tearney","sequence":"additional","affiliation":[{"name":"Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]},{"name":"Harvard-MIT Division of Health Sciences and Technology , Harvard Medical School, Massachusetts Institute of Technology, Cambridge 02139, MA ,","place":["USA"]},{"name":"Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston 02114, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7980-384X","authenticated-orcid":false,"given":"Farouc A","family":"Jaffer","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Massachusetts General Hospital, Harvard Medical School , 55 Fruit Street, Boston, MA 02114 ,","place":["USA"]},{"name":"Wellman Center for Photomedicine, Harvard Medical School, Massachusetts General Hospital , Boston, MA 02114 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2026072019572518600_ehag060-B1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1001\/jama.2018.3024","article-title":"Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with all-cause mortality in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"319","author":"Zheng","year":"2018","journal-title":"JAMA"},{"key":"2026072019572518600_ehag060-B2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072019572518600_ehag060-B3","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"14","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2026072019572518600_ehag060-B4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"2026072019572518600_ehag060-B5","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.jacc.2019.01.077","article-title":"Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention","volume":"73","author":"Guedeney","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026072019572518600_ehag060-B6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"The Lancet"},{"key":"2026072019572518600_ehag060-B7","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jama.2011.1246","article-title":"Association between serum cathepsin S and mortality in older adults","volume":"306","author":"Jobs","year":"2011","journal-title":"JAMA"},{"key":"2026072019572518600_ehag060-B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2018.09.006","article-title":"Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study","volume":"278","author":"Wuopio","year":"2018","journal-title":"Atherosclerosis"},{"key":"2026072019572518600_ehag060-B9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jacc.2022.05.055","article-title":"Cathepsin S levels and survival among patients with non-ST-segment elevation acute coronary syndromes","volume":"80","author":"Stamatelopoulos","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026072019572518600_ehag060-B10","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.122.059595","article-title":"GLP-1 Receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes","volume":"146","author":"Marx","year":"2022","journal-title":"Circulation"},{"key":"2026072019572518600_ehag060-B11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2026072019572518600_ehag060-B12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026072019572518600_ehag060-B13","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/nm.2555","article-title":"Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo","volume":"17","author":"Yoo","year":"2011","journal-title":"Nat Med"},{"key":"2026072019572518600_ehag060-B14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jacbts.2020.04.007","article-title":"Paclitaxel drug-coated balloon angioplasty suppresses progression and inflammation of experimental atherosclerosis in rabbits","volume":"5","author":"Chowdhury","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"2026072019572518600_ehag060-B15","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.jcmg.2021.06.017","article-title":"Intravascular molecular-structural assessment of arterial inflammation in preclinical atherosclerosis progression","volume":"14","author":"Osborn","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026072019572518600_ehag060-B16","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1161\/CIRCULATIONAHA.108.785881","article-title":"Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis","volume":"118","author":"Jaffer","year":"2008","journal-title":"Circulation"},{"key":"2026072019572518600_ehag060-B17","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1016\/j.jacc.2011.02.036","article-title":"Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury","volume":"57","author":"Jaffer","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026072019572518600_ehag060-B18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/ehjci\/jew228","article-title":"Everolimus-eluting stents stabilize plaque inflammation in vivo: assessment by intravascular fluorescence molecular imaging","volume":"18","author":"Press MA","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026072019572518600_ehag060-B19","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2010.02.026","article-title":"Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome","volume":"55","author":"Nicholls","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026072019572518600_ehag060-B20","doi-asserted-by":"publisher","first-page":"811790","DOI":"10.3389\/fcvm.2022.811790","article-title":"Prognostic impact of multiple lymphocyte-based inflammatory indices in acute coronary syndrome patients","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026072019572518600_ehag060-B21","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1161\/ATVBAHA.120.315612","article-title":"Near-infrared autofluorescence in atherosclerosis associates with ceroid and is generated by oxidized lipid-induced oxidative stress. Arteriosclerosis","volume":"41","author":"Albaghdadi","year":"2021","journal-title":"Thrombosis, and Vascular Biology"},{"key":"2026072019572518600_ehag060-B22","doi-asserted-by":"publisher","first-page":"e0168396","DOI":"10.1371\/journal.pone.0168396","article-title":"Liraglutide reduces both atherosclerosis and kidney inflammation in moderately uremic LDLr-\/- mice","volume":"11","author":"Bisgaard","year":"2016","journal-title":"PLoS One"},{"key":"2026072019572518600_ehag060-B23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","article-title":"The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE(-\/-) and LDLr(-\/-) mice by a mechanism that includes inflammatory pathways","volume":"3","author":"Rakipovski","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"2026072019572518600_ehag060-B24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1124\/jpet.119.258343","article-title":"Liraglutide attenuates preestablished atherosclerosis in apolipoprotein E\u2013deficient mice via regulation of immune cell phenotypes and proinflammatory mediators","volume":"370","author":"Bruen","year":"2019","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"2026072019572518600_ehag060-B25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","article-title":"Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials","volume":"15","author":"Liu","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2026072019572518600_ehag060-B26","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.bbrc.2012.07.086","article-title":"Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation","volume":"425","author":"Shiraishi","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"2026072019572518600_ehag060-B27"},{"key":"2026072019572518600_ehag060-B28","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/dom.14399","article-title":"Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials. Diabetes","volume":"23","author":"Bray","year":"2021","journal-title":"Obe Metab"},{"key":"2026072019572518600_ehag060-B29","doi-asserted-by":"publisher","first-page":"101737","DOI":"10.1016\/j.eclinm.2022.101737","article-title":"Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials","volume":"55","author":"Verma","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026072019572518600_ehag060-B30","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026072019572518600_ehag060-B31","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"2026072019572518600_ehag060-B32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/eurheartj\/ehw097","article-title":"Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology","volume":"38","author":"Bourantas","year":"2017","journal-title":"Eur Heart J"},{"key":"2026072019572518600_ehag060-B33","doi-asserted-by":"publisher","first-page":"587100","DOI":"10.3389\/fcvm.2020.587100","article-title":"Intravascular molecular imaging: near-infrared fluorescence as a new frontier","volume":"7","author":"Khraishah","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2026072019572518600_ehag060-B34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/978-1-0716-1924-7_52","article-title":"Intravascular fluorescence molecular imaging imaging of atherosclerosis","volume":"2419","author":"Chowdhury","year":"2022","journal-title":"Methods in Molecular Biology"},{"key":"2026072019572518600_ehag060-B35","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/ehjci\/jeac163","article-title":"Intravascular molecular imaging: translating pathophysiology of atherosclerosis into human disease conditions","volume":"24","author":"Seguchi","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026072019572518600_ehag060-B36","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jcmg.2015.11.020","article-title":"Clinical characterization of coronary atherosclerosis with dual-modality OCT and near-infrared autofluorescence imaging","volume":"9","author":"Ughi","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026072019572518600_ehag060-B37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41467-017-00138-x","article-title":"Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques","volume":"8","author":"Htun","year":"2017","journal-title":"Nat Commun"},{"key":"2026072019572518600_ehag060-B38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2022.01.012","article-title":"Histopathological correlation of near infrared autofluorescence in human cadaver coronary arteries","volume":"344","author":"Kunio","year":"2022","journal-title":"Atherosclerosis"},{"key":"2026072019572518600_ehag060-B39","doi-asserted-by":"publisher","first-page":"320ra4","DOI":"10.1126\/scitranslmed.aad0293","article-title":"A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer","volume":"8","author":"Whitley","year":"2016","journal-title":"Sci Transl Med"},{"key":"2026072019572518600_ehag060-B40","doi-asserted-by":"publisher","first-page":"84ra45","DOI":"10.1126\/scitranslmed.3001577","article-title":"Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques","volume":"3","author":"Vinegoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"2026072019572518600_ehag060-B41","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jcmg.2016.01.034","article-title":"Targeted near-infrared fluorescence imaging of atherosclerosis: clinical and intracoronary evaluation of indocyanine green","volume":"9","author":"Verjans","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026072019572518600_ehag060-B42","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/S0140-6736(08)60768-0","article-title":"Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies","volume":"371","author":"Mazzone","year":"2008","journal-title":"Lancet"},{"key":"2026072019572518600_ehag060-B43","doi-asserted-by":"publisher","first-page":"e984-e1010","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/28\/3800\/67726102\/ehag060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/28\/3800\/67726102\/ehag060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:57:36Z","timestamp":1784591856000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/28\/3800\/8572576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":43,"journal-issue":{"issue":"28","published-online":{"date-parts":[[2026,4,2]]},"published-print":{"date-parts":[[2026,7,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag060","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,21]]},"published":{"date-parts":[[2026,4,2]]}}}